Purple Biotech (PPBT) Net Income towards Common Stockholders (QoQ) (2014 - 2026)
Purple Biotech (PPBT) Net Income towards Common Stockholders (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Purple Biotech |
242.86 Mn |
236.43 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-99.63% |
| Dec 31, 2025 |
1,707.06% |
| Sep 30, 2025 |
20.09% |
| Jun 30, 2025 |
139.51% |
| Mar 31, 2025 |
10.49% |
| Dec 31, 2024 |
-38.16% |
| Sep 30, 2024 |
-72.50% |
| Jun 30, 2024 |
-36.17% |
| Mar 31, 2024 |
-21.77% |
| Dec 31, 2023 |
-4.13% |
| Sep 30, 2023 |
-1.99% |
| Jun 30, 2023 |
5.31% |
| Mar 31, 2023 |
-18.83% |
| Dec 31, 2022 |
24.61% |
| Sep 30, 2022 |
35.62% |
| Jun 30, 2022 |
-51.25% |
| Mar 31, 2022 |
43.87% |
| Dec 31, 2021 |
61.07% |
| Sep 30, 2021 |
-13.58% |
| Jun 30, 2021 |
-44.34% |
